BeOne Medicines (BEIGF) Treasury Shares (2015)
BeOne Medicines' (BEIGF) quarterly Treasury Shares came in at $116.8 million in Q4 2015.
Analysis
BeOne Medicines (BEIGF) Treasury Shares (2015) Analysis & Trends
BeOne Medicines (BEIGF) has reported Treasury Shares for 1 consecutive years, with $116.8 million the latest figure, recorded in Q4 2015.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $116.8 million in Q4 2015; TTM through Dec 2015 was $116.8 million, a N/A change from a year earlier, with the FY2015 full-year figure at $116.8 million, changed N/A from the prior year.
- Treasury Shares was $116.8 million for Q4 2015 at BeOne Medicines.
- Over five years, Treasury Shares peaked at $116.8 million in Q4 2015 and troughed at $116.8 million in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn | 711.62 Mn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn | 64.13 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn | -49.00 Mn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 3.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | 35.35 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | - |